After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Abbott Laboratories is listed on the NYSE in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Abbott Laboratories is $230.98B. A total of 5.04 million shares were traded on the day, compared to an average of 5.76M shares.
In the most recent transaction, Ford Robert B sold 285,388 shares of ABT for 131.17 per share on Feb 05 ’25. After the transaction, the CHAIRMAN AND CEO now owns 220,059 company shares. In a previous transaction on Feb 05 ’25, Robert B. Ford bought 285,388 shares at 131.17 per share.
Among the insiders who sold shares, ALLEN HUBERT L disposed of 131,360 shares on Jan 29 ’25 at a per-share price of $128.35. This resulted in the EXECUTIVE VICE PRESIDENT holding 184,806 shares of ABT after the transaction. In another insider transaction, ALLEN HUBERT L sold 58,428 shares at $128.07 per share on Jan 30 ’25. Company shares held by the EXECUTIVE VICE PRESIDENT now total 184,806.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Abbott Laboratories pays an annual dividend of $2.24, resulting in a dividend yield of 1.68%, and it has a price to earnings (P/E) ratio of 17.38. ABT’s most recent ex-dividend date was 2.08% when it declared a $0.59 quarterly dividend that was paid in cash on 1/15/2025. Previously, the company paid the dividend on 10/15/2024 with an ex-dividend date of 1.9%. The ABT stock dividend was $0.55 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ABT has a high of $132.65 and a low of $99.71.
As of this writing, ABT has an earnings estimate of $1.06 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $1.08 per share and a lower estimate of $0.98.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ABT’s latest balance sheet shows that the firm has $10.25B in Cash & Short Term Investments as of fiscal 2021. There were $19.01B in debt and $13.11B in liabilities at the time. Its Book Value Per Share was $22.94, while its Total Shareholder’s Equity was $36.02B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABT is Buy with a score of 4.44.
